TEHRAN - The World Health Organization (WHO) has achieved a significant milestone by successfully facilitating the procurement of 2.79 million Vaccine Vial Monitors (VVMs) for the Islamic Republic of Iran’s oral polio vaccine program.

This strategic move that was funded by the Razi Vaccine and Serum Research Institute marks a substantial leap forward in strengthening the country’s national immunization efforts.

The shipment of VVMs, temperature-sensitive devices crucial for vaccine storage and transportation, arrived through Imam Khomeini International Airport.

The consignment was received jointly by the Razi Vaccine and Serum Research Institute and the WHO Country Office in the Islamic Republic of Iran. These VVMs were procured from a reputable international supplier.

Ali Es’haghi, Director General of the Razi Vaccine & Serum Research Institute affiliated with the Government of the Islamic Republic of Iran, indicated that the collaborative achievement was the result of concerted efforts across multiple levels.

He mentioned that the Razi Serum Vaccine Research Institute, the Ministry of Health and Medical Education, Iran Food and Drug Administration (IFDA), The Ministry of Industry, Mine and Trade, the WHO Country Office in the Islamic Republic of Iran, WHO Headquarters, and the Eastern Mediterranean Regional Office (EMRO) worked tirelessly for nearly two years to navigate a complex procurement process.

According to him, the initiative began in November 2022 following a request from the Razi Institute.

Hamid Jafari, Polio Director at EMRO, conducted a mission to Iran in August 2022, laying the groundwork for this critical endeavor.

Es’haghi also noted that in December 2022, a Memorandum of Understanding (MOU) was signed between the Razi Institute and the WHO country office, formalizing the purchase of these essential supplies for use inside the country.

VVMs play a pivotal role in maintaining vaccine potency and effectiveness. Placed on the vaccine vials, these devices ensure that vaccines remain within the optimal temperature range during storage and transportation. By safeguarding the health of children, they contribute significantly to the global effort to eradicate polio.

Syed Jaffar Hussain, WHO Representative and Head of Mission to the Islamic Republic of Iran, emphasized the importance of this achievement: “Securing these VVMs is a crucial step in ensuring the safety and efficacy of vaccines. It reflects our shared commitment to improving health outcomes for all in the world and in the Islamic Republic of Iran.”

This technology transfer not only represents a remarkable advancement but also underscores WHO’s unwavering dedication to supporting Iran’s national immunization program.

By prioritizing safe storage and transportation of vaccines, the VVMs will protect children from preventable diseases, contributing to a healthier society. This project embodies the humanitarian principles that guide WHO’s mission toward a healthier future for all.